Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
NCT ID:
NCT04740918
Group ID:
EG001
Title:
Trastuzumab Emtansine 3.6 mg + Atezolizumab 1200 mg
Description:
Participants received trastuzumab emtansine, 3.6 mg, Q3W as an IV infusion in combination with atezolizumab, 1200 mg, Q3W as an IV infusion on Day 1 of each 21-day cycle until radiographic disease progression, intolerable toxicity, withdrawal of consent, death or study termination by the sponsor.
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
47
Other Number Affected:
46
Other Number At Risk:
47
Study:
NCT04740918
Results Section:
NCT04740918
Adverse Events Module:
NCT04740918